Affordable Access

Lymphocytosis decline is not responsible for tumor progression in cancer patients chronically treated with interleukin-2.

Authors
Type
Published Article
Journal
Tumori Journal
0300-8916
Publisher
"Wichtig Publishing, SRL"
Publication Date
Volume
80
Issue
4
Pages
283–285
Identifiers
PMID: 7974799
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments